Idea principal
In 833 adults with dysglycemia, modified fasting therapy was followed by a fall of 7.73 mmHg in systolic and 4.76 mmHg in diastolic blood pressure, and weight loss did not significantly account for it (indirect effects p = 0.588 and 0.636). With no control group, the before-and-after change cannot be separated from other influences in a supervised fasting setting.
Study design
Estudio de cohorte
Reading basis
Published abstract
Reading focus
Association & confounding
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Fasting programs often lower blood pressure, but it is unclear whether that is just a result of losing weight. The authors tested how much modified fasting therapy changed blood pressure in people with dysglycemia, whether weight loss mediated the change, and whether age, sex or baseline HbA1c altered the response.
Población y método
Retrospective cohort of 833 dysglycemic adults who underwent modified fasting therapy, with blood pressure, body weight and laboratory values measured before and after. Linear mixed models estimated the change in systolic (SBP) and diastolic (DBP) blood pressure, adjusted for age, sex, baseline body mass index (BMI), glycosylated hemoglobin (HbA1c) and baseline blood pressure. Mediation analysis used the MEMORE macro and the wsMed package, and interaction terms tested modification by age, sex and baseline HbA1c. The abstract does not report the fasting length or follow-up time.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Fasting therapy reduced SBP by 7.73 mmHg (95% CI -8.64 to -6.82, p < 0.001) and DBP by 4.76 mmHg (95% CI -5.39 to -4.12, p < 0.001).
- 2Weight loss did not significantly mediate the blood pressure fall: indirect effect -0.22 for SBP (p = 0.588) and 0.09 for DBP (p = 0.636).
- 3The effect was modified by age, sex and baseline HbA1c, with larger reductions in younger patients, males and those with higher HbA1c.
Límites e incertidumbre
- 1There was no comparison group, so the before-after drop could include other changes during the program, such as diet, medication or regression to the mean.
- 2Retrospective data from patients who chose or were referred for fasting therapy may not reflect other people, and the abstract does not give the length of fasting or how long the effect lasted.
- 3Not finding a significant weight-loss mediation does not prove weight is irrelevant, especially if body weight was the only mediator tested.
- 4Interaction findings for age, sex and HbA1c are subgroup analyses; this reading is based on the abstract only.
Relevancia práctica
The results suggest a supervised fasting program can come with a drop in blood pressure that is not just explained by weight loss. They do not show that fasting is safe or suitable for you, and anyone with diabetes, high blood pressure or on medication should plan any fasting with their clinician.
Tus datos
If you do any structured eating change, a home cuff gives the most useful data: measure at the same time and posture each day and compare weekly averages against your baseline. Log weight on the same scale so you can see whether blood pressure and weight move together.
Cómo interpretar la evidencia
Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Objective
To evaluate the effect of modified fasting therapy on blood pressure in dysglycemic adults and to examine the mediating role of weight loss and modifying effects of age, sex, and baseline glycemic status.
Methods
This retrospective cohort study included 833 dysglycemic adults who underwent modified fasting therapy. Blood pressure, body weight, and laboratory parameters were measured before and after the intervention. Linear mixed models were used to estimate the effect of fasting on systolic blood pressure (SBP) and diastolic blood pressure (DBP), with adjustment for age, sex, baseline body mass index (BMI), glycosylated hemoglobin (HbA1c), and baseline blood pressure. Mediation analyses were performed using "MEMORE macro" and "wsMed" package to examine the mediating role of weight loss. Interaction terms were included to test effect modification by age, sex, and baseline HbA1c.
Results
Fasting therapy significantly reduced SBP (-7.73 mmHg, 95% CI: -8.64 to -6.82, p < 0.001) and DBP (-4.76 mmHg, 95% CI: -5.39 to -4.12, p < 0.001). Mediation analyses revealed that weight loss did not significantly mediate the blood pressure-lowering effect for either SBP (indirect effect: -0.22, p = 0.588) or DBP (indirect effect: 0.09, p = 0.636). The fasting effect was significantly modified by age, sex, and baseline HbA1c, with greater reductions observed in younger patients, males, and those with higher HbA1c levels.
Conclusions
Modified fasting therapy significantly reduces blood pressure in dysglycemic adults independent of weight loss. Age, sex, and baseline HbA1c modify the response, suggesting that personalized approaches may optimize the benefits of fasting-based interventions.
Fuentes y atribución
Modified fasting therapy reduces blood pressure independent of weight loss, moderated by age, sex, and HbA1c: a retrospective mediation analysis in dysglycemic patients.
Ye Z, Sun J, Zhang T, Feng J, Zeng D, Qin Y, Zhang L, Qin J, Liu T.
Frontiers in endocrinology · 2026-10-07
DOI: 10.3389/fendo.2026.1976220 ↗PubMed · 42908842 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

